PRKCSH
Glucosidase 2 subunit beta
Also known as: G19P1, GIIB, GLU2B_HUMAN, PCLD, PLD1, VASAP-60
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P14314
- Gene
- PRKCSH
- Ensembl
- ENSG00000130175
- Chromosome
- 19
- Canonical length
- 528 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Endoplasmic reticulum
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes the beta-subunit of glucosidase II, an N-linked glycan-processing enzyme in the endoplasmic reticulum. The encoded protein is an acidic phosphoprotein known to be a substrate for protein kinase C. Mutations in this gene have been associated with the autosomal dominant polycystic liver disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
Canonical amino-acid sequenceUniProt
528 residues, UniProt reviewed canonical sequence.
>P14314|PRKCSH
1 MLLPLLLLLP MCWAVEVKRP RGVSLTNHHF YDESKPFTCL DGSATIPFDQ VNDDYCDCKD
61 GSDEPGTAAC PNGSFHCTNT GYKPLYIPSN RVNDGVCDCC DGTDEYNSGV ICENTCKEKG
121 RKERESLQQM AEVTREGFRL KKILIEDWKK AREEKQKKLI ELQAGKKSLE DQVEMLRTVK
181 EEAEKPEREA KEQHQKLWEE QLAAAKAQQE QELAADAFKE LDDDMDGTVS VTELQTHPEL
241 DTDGDGALSE AEAQALLSGD TQTDATSFYD RVWAAIRDKY RSEALPTDLP APSAPDLTEP
301 KEEQPPVPSS PTEEEEEEEE EEEEEAEEEE EEEDSEEAPP PLSPPQPASP AEEDKMPPYD
361 EQTQAFIDAA QEARNKFEEA ERSLKDMEES IRNLEQEISF DFGPNGEFAY LYSQCYELTT
421 NEYVYRLCPF KLVSQKPKLG GSPTSLGTWG SWIGPDHDKF SAMKYEQGTG CWQGPNRSTT
481 VRLLCGKETM VTSTTEPSRC EYLMELMTPA ACPEPPPEAP TEDDHDELLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRKCSH can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 176 nTPM
Expression across tissuesHPA
Tissue
- ovary: 176 nTPM
- pancreas: 176 nTPM
- bone marrow: 160 nTPM
- liver: 145 nTPM
- salivary gland: 138 nTPM
- spinal cord: 131 nTPM
Single-cell type
- extravillous trophoblasts: 262 nCPM
- decidual stromal cells: 208 nCPM
- cytotrophoblasts: 207 nCPM
- migrating cytotrophoblasts: 187 nCPM
- enterocytes: 180 nCPM
- syncytiotrophoblasts: 161 nCPM
Immune cell
- plasmacytoid DC: 76 nTPM
- neutrophil: 57 nTPM
- classical monocyte: 47 nTPM
- eosinophil: 45 nTPM
- MAIT T-cell: 43 nTPM
- non-classical monocyte: 41 nTPM
Brain region
- choroid plexus: 125 nTPM
- medulla oblongata: 122 nTPM
- white matter: 115 nTPM
- basal ganglia: 113 nTPM
- cerebellum: 111 nTPM
- midbrain: 108 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PRKCSH.
Disease | AllUniProt
Conditions PRKCSH is implicated in, by any mechanism.
- Polycystic liver disease 1 with or without kidney cysts (PCLD1) MIM:174050
Disease | GeneticClinVar
45 pathogenic / likely-pathogenic of 536 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Polycystic liver disease 1
- Autosomal dominant polycystic liver disease
- PRKCSH-related disorder
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.76
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.53
- DepMap mean gene effect
- -0.18
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- EF-hand domain
- Mannose-6-phosphate receptor binding domain superfamily
- EF-hand domain pair
- EF-Hand 1, calcium-binding site
- LDL receptor-like superfamily
- Glucosidase II beta subunit-like
- MRH domain
- EF hand
- Glucosidase II beta subunit, N-terminal
- Glucosidase 2 subunit beta-like
- Glucosidase II beta subunit-like
- Glucosidase II beta subunit-like protein
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PRKCSH in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRKCSH as an antibody target. Whether an autoantibody or antibody against PRKCSH could matter depends on whether native PRKCSH is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRKCSH is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PRKCSH as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...